Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen
44%
Docetaxel
33%
Prostate Specific Antigen
27%
Chemotherapy
21%
Calcitriol
17%
Malignant Neoplasm
16%
Disease
15%
Neoplasm
14%
Overall Survival
10%
Mitoxantrone
9%
Placebo
7%
Castration Resistant Prostate Cancer
7%
Biological Marker
6%
Androgen Receptor
5%
Gleason Score
5%
Diethylstilbestrol
5%
Transdermal
5%
Medicine and Dentistry
Prostate Cancer
75%
Androgen
24%
Prostate Specific Antigen
21%
Malignant Neoplasm
18%
Neoplasm
18%
Prostatectomy
17%
Docetaxel
16%
Disease
15%
Biopsy
13%
Radiation Therapy
10%
Androgen Deprivation Therapy
10%
Gleason Score
8%
External Beam Radiotherapy
7%
Overall Survival
7%
Calcitriol
7%
Prostate Carcinoma
7%
Recurrent Disease
6%
Lymph Node
6%
Prostate Biopsy
6%
Brachytherapy
6%
Recurrence Free Survival
6%
Mitoxantrone
5%
Needle Biopsy
5%
Keyphrases
Prostate Cancer
20%
Docetaxel
15%
High-grade Prostate Cancer
15%
Prostate-specific Antigen
13%
Hormone-sensitive Prostate Cancer
12%
Chemotherapy
11%
High Risk
8%
Prostate Cancer Cells
7%
Prostatectomy
7%
Prostate Cancer Risk
7%
Confidence Interval
6%
Total Prostate-specific Antigen
6%
Abarelix
6%
Androgen Deprivation Therapy
5%
Calcitriol
5%